TABITHA PINKLEY: Open Payments
NPI 1346866316 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 122 payments from 34 companies in 2025. Trend: 2023 $165 · 2024 $3,075 · 2025 $2,357
Food & beverage: $2,318Education: $39
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $448 |
| Vanda Pharmaceuticals Inc. | 10 | $245 |
| Aimmune Therapeutics, Inc. | 6 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $121 |
| Teva Pharmaceuticals USA, Inc. | 3 | $118 |
| E.R. Squibb & Sons, L.L.C. | 3 | $110 |
| GlaxoSmithKline, LLC. | 6 | $95 |
| Novo Nordisk Inc | 6 | $89 |
| Lilly USA, LLC | 4 | $84 |
| PFIZER INC. | 4 | $79 |
Products named: FANAPT, QULIPTA, ZENPEP, VRAYLAR, CAPLYTA, ELIQUIS, TRELEGY ELLIPTA, COBENFY.
Industry payments across MO — which companies pay providers there.
